Keiji Tanese

Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy

Yoshio Nakamura, Shigehisa Kitano, Akira Takahashi et al. · Oncotarget · 2016 · 160 citations · Full text

Medicine, Immunology, Oncology +17

G-Protein-Coupled Receptor GPR49 is Up-regulated in Basal Cell Carcinoma and Promotes Cell Proliferation and Tumor Formation

Keiji Tanese, Mariko Fukuma, Taketo Yamada et al. · American Journal Of Pathology · 2008 · 141 citations · Full text

Medicine, Molecular Biology, Oncology +16

Cell Surface CD74–MIF Interactions Drive Melanoma Survival in Response to Interferon-γ

Keiji Tanese, Yuuri Hashimoto, Zuzana Berkova et al. · Journal of Investigative Dermatology · 2015 · 95 citations · Full text

Medicine, Immunology, Oncology +10

Identification of mutations in the prostaglandin transporter gene SLCO2A1 and its phenotype–genotype correlation in Japanese patients with pachydermoperiostosis

Takashi Sasaki, Hironori Niizeki, Atsushi Shimizu et al. · Journal of Dermatological Science · 2012 · 83 citations

Life Sciences, Genetics, Molecular Genetics +9

Macrophage migration inhibitory factor‐<scp>CD</scp>74 interaction regulates the expression of programmed cell death ligand 1 in melanoma cells

Masako Imaoka, Keiji Tanese, Yohei Masugi et al. · Cancer Science · 2019 · 56 citations · Full text

Medicine, Immunology, Oncology +17